ACHP supports Medicare Advantage policies that prioritize the health of seniors and strengthen the program.
LETTER — Response to the 2022 Physician Fee Schedule
ACHP’s response to the 2022 Physician Fee Schedule urges CMS to expand telehealth and reaffirms ACHP’s commitment to health equity.
RELEASE — Fourteen Health Care Organizations Commit to Mandating COVID-19 Vaccines
ACHP and other health care organizations in and around Washington, D.C. are mandating COVID-19 vaccines a condition of returning to offices.
INFOGRAPHIC – The Impact of High-Cost Specialty Drugs
If the constant price hikes of high-priced specialty drugs are left unchecked, prescription drug costs will continue to explode.
LETTER — Letter to Congressional Leadership on Vital Health Care Issues for Reconciliation Bill
ACHP urged Congressional leaders to address vital health care issues affecting Americans across the nation in the reconciliation package.
VIDEO — Tackling High-Cost Specialty Drugs and Preserving Patient Centered Innovation (Webinar)
ACHP examines how organizations are managing high-cost specialty drugs to ensure patients get the drugs they need without breaking the bank.
LETTER — Letter to House Leadership on Continuous Eligibility in Medicaid and CHIP
The Alliance of Community Health Plans commends House Leadership for supporting efforts to enact continuous eligibility in Medicaid and CHIP.
LETTER — Letter to Senate Leadership on Continuous Eligibility in Medicaid and CHIP
The Alliance of Community Health Plans commends House Leadership for supporting efforts to enact continuous eligibility in Medicaid and CHIP.
ISSUE BRIEF — Lowering Drug Costs through Transparency and Competition
ACHP proposes bold reforms aimed at lowering drug costs by promoting transparency, competition and innovation.
POLICY POSITIONING — Curbing High Drug Costs
ACHP’s bipartisan policy recommendations will help hold drug makers accountable and curb exorbitantly high drug costs.